Nadav Friedmann

Nadav Friedmann (senior executive) discloses dealings in Filana Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 15 March 2006 to 3 October 2022, the count stands at 62 filings.

The open-market side counts 8 purchases for €110k alongside 16 sales for €856k. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 15 share grants and 11 option exercises.

Half of the purchases are above €13k and half below.

The latest filing, published on 3 October 2022, reports an option exercise of €9,059 in Filana Therapeutics, Inc. The last insider purchase was made public on 8 December 2009, 6,179 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.